title: Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
authors.affiliation: The George M O'Brien Urology Research Center, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Cozzi
authors.forename: S
authors.initials: S
authors.lastname: Malhotra
authors.forename: P
authors.initials: P
authors.lastname: McAuliffe
authors.forename: D A
authors.initials: DA
authors.lastname: Kooby
authors.forename: H J
authors.initials: HJ
authors.lastname: Federoff
authors.forename: B
authors.initials: B
authors.lastname: Huryk
authors.forename: P
authors.initials: P
authors.lastname: Johnson
authors.forename: P T
authors.initials: PT
authors.lastname: Scardino
authors.forename: W D
authors.initials: WD
authors.lastname: Heston
authors.forename: Y
authors.initials: Y
authors.lastname: Fong
mesh_terms: D000818:Animals; D001691:Biological Therapy / Q000379:methods*; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D018139:Simplexvirus / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology*; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000628:therapy* / Q000821:virology*; D014779:Virus Replication